CSRxP COMMENDS ADMINISTRATION FOR CHALLENGING MORE THAN 200 OF BIG PHARMA’S SHAM PATENTS THAT BLOCK COMPETITION AND KEEP DRUG PRICES HIGH
FTC’s Continued Crackdown on Bogus Patents Listed in the Orange Book Will… Read More

FTC’s Continued Crackdown on Bogus Patents Listed in the Orange Book Will… Read More
Administration Rightly Diagnoses Big Pharma’s Egregious Pricing Practices as… Read More
Lawmakers Should Focus on Market-Based Solutions That Hold Big Pharma… Read More
Campaign Spoofs Big Pharma’s Direct-to-Consumer (DTC) Ads While Highlighting… Read More
Lawmakers Should Advance Bipartisan Solution to Crack Down on Anti-Competitive… Read More
Committee Markup Advances Legislation to Crack Down on Big Pharma’s… Read More
BIG PHARMA’S PATENT ABUSE IS THE ROOT CAUSE OF OUT-OF-CONTROL PRESCRIPTION… Read More
Study Finds Reducing or Taxing Brand Name Drug Companies’ Nearly $14 Billion… Read More
Cracking Down on Anti-Competitive Tactics Like Patent-Thicketing and… Read More
Campaign Looks Forward to Working with Kennedy and the Administration to Lower… Read More
Brand Name Drug Companies Signal Business-as-Usual Approach to Price-Gouging… Read More
Campaign Will Work with Lawmakers in the New Congress and the New… Read More